QUIDELORTHO CORP Interest Payable, Current
QUIDELORTHO CORP (QDEL) had Interest Payable, Current of $17.60 million as of 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-07
- 2026-06-28: Interest Payable, Current $17.60M.
- 2026-03-29: Interest Payable, Current $16.70M.
- 2025-12-28: Interest Payable, Current $48.10M.
- 2025-09-28: Interest Payable, Current $22.40M.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-28 | $17.60M 10-Q · filed 2026-08-07 |
| 2026-03-29 | $16.70M 10-Q · filed 2026-05-06 |
| 2025-12-28 | $48.10M 10-Q · filed 2026-08-07 |
| 2025-09-28 | $22.40M 10-Q · filed 2025-11-06 |
| 2025-06-29 | $14.00M 10-Q · filed 2025-08-06 |
| 2025-03-30 | $13.50M 10-Q · filed 2025-05-08 |
| 2024-12-29 | $39.00M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |